Viewing Study NCT01904604

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2026-01-12 @ 10:27 PM
Study NCT ID: NCT01904604
Status: COMPLETED
Last Update Posted: 2019-07-01
First Post: 2013-07-15
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peanut Hypersensitivity View
None Food Hypersensitivity View
None Hypersensitivity View
None Hypersensitivity, Immediate View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Peanut Allergy View
None Food Allergy View
None Viaskin peanut patch View
None Allergen Immunotherapy View
None Epicutaneous Immunotherapy View
None Whole peanut extract View
None Allergenic product View
None Immediate hypersensitivity View